Addison's disease

Autoimmune polyendocrine disorders

Hypoparathyroidism

Endocrinology

Academic article

• Mikael Thomassen Neset; Roy Miodini Nilsen; Kristian Løvås et al. (2025). Exploring tear fluid biomarkers and the ocular surface in thyroid eye disease. (external link)
• Mikael Thomassen Neset; Arve Ulvik; Kristian Løvås et al. (2025). Insight into the metabolic shifts in Graves’ hyperthyroidism: a study of acylcarnitine and lipid profiles. (external link)
• Dmytro Fishman; Kai Kisand; Christina Hertel et al. (2017). Autoantibody Repertoire in APECED Patients Targets Two Distinct Subgroups of Proteins. (external link)
• Iren Drange Hjellestad; Eirik Søfteland; Roy Miodini Nilsen et al. (2016). Abdominal aortic aneurysms - glycaemic status and mortality. (external link)
• Paal Methlie; Eystein Sverre Husebye; Simon Steinar Hustad et al. (2011). Grapefruit juice and licorice increase cortisol availability in patients with Addison's disease. (external link)
• Agnethe Berglund; Line Cleemann; Bergithe Eikeland Oftedal et al. (2018). 21-hydroxylase autoantibodies are more prevalent in Turner syndrome but without an association to the autoimmune polyendocrine syndrome type I. (external link)
• Kine Susann Waade Edvardsen; Alexander Hellesen; Eystein Sverre Husebye et al. (2016). Analysis of cellular and humoral immune responses against cytomegalovirus in patients with autoimmune Addison's disease. (external link)
• Ingrid Nermoen; Ivar Følling; Kjetil Vegge et al. (2009). Two adults with adrenal myelolipoma and 21-hydroxylase deficiency. (external link)
• Anna Chuprin; Ayelet Avin; Yael Goldfarb et al. (2015). The deacetylase Sirt1 is an essential regulator of Aire-mediated induction of central immunological tolerance. (external link)
• Marianne Astor; Wendy Zhu; Sigrídur Björnsdóttir et al. (2018). Is there a need for an emergency card in hypoparathyroidism?. (external link)
• Anette Susanne Bøe; Per Morten Knappskog; Anne Grete Myhre et al. (2002). Mutational analysis of the autoimmune regulator gene in sporadic autoimmune Addison`s disease can reveal patients with unidentified autoimmune polyendocrine syndrome type I. (external link)
• Eystein Sverre Husebye (2009). Skin changes as diagnostic aid. (external link)
• Takaki Asano; Bertrand Boisson; Fanny Onodi et al. (2021). X-linked recessive TLR7 deficiency in ~1% of men under 60 years old with life-threatening COVID-19. (external link)
• Iren Drange Hjellestad; Eirik Wigtil Søfteland; Eystein Sverre Husebye et al. (2019). HbA1c predicts long-term postoperative mortality in patients with unknown glycemic status at admission for vascular surgery: An exploratory study.. (external link)
• Katerina Simunkova; Kristian Løvås; Paal Methlie et al. (2022). Pulsatile Subcutaneous Hydrocortisone Replacement in Primary Adrenal Insufficiency. (external link)
• Kai Kisand; Maire Link; Anette Susanne Bøe Wolff et al. (2008). Interferon autoantibodies associated with AIRE deficiency decrease the expression of IFN-stimulated genes. (external link)
• Paul Bastard; Sara E. Vazquez; Jamin Liu et al. (2023). Vaccine breakthrough hypoxemic COVID-19 pneumonia in patients with auto-Abs neutralizing type I IFNs. (external link)
• F Skjöldberg; L Grimelius; F Rorsman et al. (1998). A family with hereditary extra-adrenal paragangliomas without evidence for mutations in the Von Hippel Lindau disease or ret genes. (external link)
• Sigrid Aslaksen; Anette Susanne Bøe Wolff; Magnus Dehli Vigeland et al. (2019). Identification and characterization of rare Toll-like receptor 3 variants in patients with autoimmune Addison’s disease. (external link)
• Ingeborg Brønstad; Beate Skinningsrud; Eirik Bratland et al. (2014). CYP21A2 polymorphisms in patients with autoimmune Addison's disease, and linkage disequilibrium to HLA risk alleles. (external link)
• Grethe Åstrøm Ueland; Paal Methlie; Dag Eirik Jøssang et al. (2018). Adrenal Venous Sampling for Assessment of Autonomous Cortisol Secretion. (external link)
• Saila Laakso; Elina Hopolainen; Corrado Betterle et al. (2021). Pregnancy Outcome in Women With APECED (APS-1): A Multicenter Study on 43 Females With 83 Pregnancies. (external link)
• Elinor Margrethe Vogt; Eirik Bratland; Siren Berland et al. (2024). Improving diagnostic precision in primary ovarian insufficiency using comprehensive genetic and autoantibody testing. (external link)
• Grethe Åstrøm Ueland; Hans Olav Ueland; Ann-Elin Meling Stokland et al. (2023). Prevalence, Risk Factors, and Clinical and Biochemical Characteristics of Alemtuzumab-Induced Graves Disease. (external link)
• Anette Susanne Bøe Wolff; Anna L. Mitchell; Heather J. Cordell et al. (2015). CTLA-4 as a genetic determinant in autoimmune Addison's disease. (external link)
• Åse Bjorvatn Sævik; Anna Karin Åkerman; Kaja Grønning et al. (2017). Clues for early detection of autoimmune Addison's disease - myths and realities. (external link)
• Maribel Aranda-Guillén; Ellen Christine Røyrvik; Sara Fletcher-Sandersjöö et al. (2023). A polygenic risk score to help discriminate primary adrenal insufficiency of different etiologies. (external link)
• Andrea D. Short; Alisdair Boag; Brian Catchpole et al. (2013). A candidate gene analysis of canine hypoadrenocorticism in 3 dog breeds. (external link)
• Caleigh Mandel-Brehm; Sara E. Vazquez; Christopher Liverman et al. (2023). Autoantibodies to Perilipin-1 Define a Subset of Acquired Generalized Lipodystrophy. (external link)
• Daniel Eriksson; Ellen Christine Røyrvik; Maribel Aranda-Guillen et al. (2021). GWAS for autoimmune Addison's disease identifies multiple risk loci and highlights AIRE in disease susceptibility. (external link)
• K Løvås; Martina M. Erichsen; ES Husebye et al. (2005). Primær binyrebarksvikt - årsaker, diagnostikk og behandling. (external link)
• Ng’weina Francis Magitta; AS Bøe; S Johansson et al. (2008). A coding polymorphism in NALP1 confers risk for autoimmune Addison's disease and type 1 diabetes. (external link)
• Ann-Elin Meling Stokland; Marie Austdal; Bjørn Gunnar Nedrebø et al. (2023). Outcomes of Patients With Graves Disease 25 Years After Initiating Antithyroid Drug Therapy. (external link)
• M Stridsberg; Eystein S.Junior Husebye (1997). Chromogranin A and chromogranin B in phaeochromocytoma. (external link)
• Ann-Elin Meling Stokland; Grethe Åstrøm Ueland; Kari Lima et al. (2022). Autoimmune Thyroid Disorders in Autoimmune Addison Disease. (external link)
• Leila S. Sozaeva; Lubov I Zilberman; Galina N Svetlova et al. (2018). Clinical and immunological characteristics of diabetes mellitus in patients with autoimmune polyglandular syndrome type 1 in Russia. (external link)
• Nils Landegren; Donald Sharon; Eva Freyhult et al. (2016). Proteome-wide survey of the autoimmune target repertoire in autoimmune polyendocrine syndrome type 1. (external link)
• Anette Susanne Bøe Wolff; Adrien Katalin Sarkadi; László Maródi et al. (2013). Anti-cytokine autoantibodies preceding onset of autoimmune polyendocrine syndrome type I features in early childhood. (external link)
• Adrianna Jebrzycka; Lars Breivik; David William Peter Dolan et al. (2025). Aire-dependent interferon signalling shapes thymocyte maturation and central tolerance in mice. (external link)
• Thea Sjøgren; Jan-Inge Bjune; Eystein Sverre Husebye et al. (2024). Regulatory T cells in autoimmune primary adrenal insufficiency. (external link)
• Anne Grethe Myhre; H. Aarsetøy; D.E. Undlien et al. (2003). High frequency of coeliac disease among patients with autoimmune adrenocortical failure. (external link)
• Grethe Åstrøm Ueland; Thea Grinde; Paal Methlie et al. (2020). Diagnostic testing of autonomous cortisol secretion in adrenal incidentalomas. (external link)
• Andrea D. Short; Brian Catchpole; Alisdair Boag et al. (2014). Putative candidate genes for canine hypoadrenocorticism (Addison's disease) in multiple dog breeds. (external link)
• Felix Beuschlein; Tobias Else; Irina Bancos et al. (2024). European Society of Endocrinology and Endocrine Society Joint Clinical Guideline: Diagnosis and Therapy of Glucocorticoid-induced Adrenal Insufficiency. (external link)
• A-G Myhre; P Bjørses; A Dalen et al. (1998). Three sisters with Addison's disease. (external link)
• Sara Öster; Daniela Esposito; Maribel Aranda-Guillén et al. (2023). Self-management and hospitalization in 615 Swedish patients with Addison's disease during the coronavirus disease 2019 pandemic: a retrospective study. (external link)
• Marissa Penna-Martinez; Gesine Meyer; Anette Susanne Bøe Wolff et al. (2021). Vitamin D status and pathway genes in five European autoimmune Addison's disease cohorts. (external link)
• Iivo Hetemäki; Hanna Jarva; Nicolas Kluger et al. (2016). Anticommensal responses are associated with regulatory T cell defect in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy patients. (external link)
• Eystein S.Junior Husebye; Eirik Bratland; Geir Bredholt et al. (2006). The substrate-binding domain of 21-hydroxylase, the main autoantigen in autoimmune Addison's disease, is an immunodominant T cell epitope. (external link)
• Ingeborg Brønstad; Lars Ertesvåg Breivik; Paal Methlie et al. (2014). Functional studies of novel CYP21A2 mutations detected in Norwegian patients with congenital adrenal hyperplasia. (external link)
• Beate Skinningsrud; Eystein Sverre Husebye; Simon H. Pearce et al. (2008). Polymorphisms in CLEC16A and CIITA at 16p13 are associated with primary adrenal insufficiency. (external link)
• Marianne Astor; Kristian Løvås; Anette Susanne Bøe Wolff et al. (2015). Hypomagnesemia and functional hypoparathyroidism due to novel mutations in the Mg-channel TRPM6. (external link)
• H.H. Hedstrand; J Perheentupa; O Ekwall et al. (1999). Antibodies Against Hair Follicles are Associated with Alopecia Totalis in Autoimmune Polyendocrine Syndrome Type I. (external link)
• Anne Grethe Myhre; M. Halonen; P. Eskelin et al. (2001). Autoimmune polyendocrine syndrome type 1 (APS I) in Norway. (external link)
• Sophie Bensing; Sergueï O. Fetissov; Jan Mulder et al. (2007). Pituitary autoantibodies in autoimmune polyendocrine syndrome type 1. (external link)
• Eva Martina Moter Erichsen; Eystein Sverre Husebye; Trond Melbye Michelsen et al. (2010). Sexuality and Fertility in Women with Addison's Disease. (external link)
• Annika Søderbergh; A.G. Myhre; Olov Ekwall et al. (2004). Prevalence and clinical associations of 10 defined autoantibodies in autoimmune polyendocrine syndrome type I. (external link)
• Jonathan Massey; Alisdair Boag; Andrea D. Short et al. (2013). MHC class II association study in eight breeds of dog with hypoadrenocorticism. (external link)
• Bergithe Eikeland Oftedal; Amund Holte Berger; Øyvind Bruserud et al. (2023). A partial form of AIRE deficiency underlies a mild form of autoimmune polyendocrine syndrome type 1. (external link)
• Eirik Bratland; Eystein Sverre Husebye (2011). Cellular immunity and immunopathology in autoimmune Addison’s disease. (external link)
• Anne Grethe Myhre; A. Stray-Pedersen; S. Spangen et al. (2004). Chronic mucocutaneous candidiasis and primary hypothyroidism in two families. (external link)
• A. Storstein; Sissel Evy Monstad; Hanne Linda Nakkestad et al. (2004). Paraneoplastic antibodies against HuD detected by a sensitive radiobinding assay. (external link)
• Agnieszka Pazderska; Bergithe Eikeland Oftedal; Catherine M. Napier et al. (2016). A variant in the BACH2 gene is associated with susceptibility to autoimmune addison's disease in humans. (external link)
• Håkan Hedstrand; Olov Ekwall; Jan Haavik et al. (2000). Identification of tyrosine hydroxylase as an autoantigen in autoimmune polyendocrine syndrome type I. (external link)
• Mohammad Alimohammadi; Noémie Dubois; Filip Sköldberg et al. (2009). Pulmonary autoimmunity as a feature of autoimmune polyendocrine syndrome type 1 and identification of KCNRG as a bronchial autoantigen. (external link)
• Haydee Artaza; Daniel Eriksson; Ksenia Lavrichenko et al. (2024). Rare copy number variation in autoimmune Addison’s disease. (external link)
• O Ekwall; HH Hedstrand; Jan Haavik et al. (2000). Pteridin dependent hydroxylases as autoantigens in autoimmune polyendocrine syndrome type 1. (external link)
• Eystein Husebye; Anette Susanne Bøe; Fredrik Rorsman et al. (2000). Inhibition of aromatic L-amino acid decarboxylase activity by human autoantibodies. (external link)
• [Mangler fornavn] Gebre-Medhin; Eystein S.Junior Husebye; H Mallmin et al. (2000). Oral dehydroepiandrosterone (DHEA) replacement therapy in women with Addison's disease. (external link)
• Elinor Margrethe Chelsom Vogt; Francisco Gomez Real; Eystein Sverre Husebye et al. (2022). Premature menopause and autoimmune primary ovarian insufficiency in two international multi-center cohorts. (external link)
• Kaja Grønning; Archana Sharma; Maria Adele Mastroianni et al. (2020). Primary adrenal lymphoma as a cause of adrenal insufficiency, a report of two cases. (external link)
• Casey J.A. Smith; Mikael Oscarson; Lars Rönnblom et al. (2011). TSGA10 – A target for autoantibodies in autoimmune polyendocrine syndrome Type 1 and systemic lupus erythematosus. (external link)
• Anne Blomhoff; EH Kemp; DJ Gawkrodger et al. (2005). CTLA4 polymorphisms are associated with vitiligo, in patients with concomitant autoimmune diseases. (external link)
• Hans Olav Ueland; Arve Ulvik; Kristian Løvås et al. (2023). Systemic Activation of the Kynurenine Pathway in Graves Disease With and Without Ophthalmopathy. (external link)
• Antonella Meloni; Maria Furcas; Filomena Cetani et al. (2008). Autoantibodies against Type I Interferons as an Additional Diagnostic Criterion for Autoimmune Polyendocrine Syndrome Type I. (external link)
• Eystein S.Junior Husebye; G Gebre-Medhin; T Tuomi et al. (1997). Autoantibodies against aromatic L-amino acid decarboxylase in autoimmune polyendocrine syndrome type I correlate with the presence of autoimmune hepatitis and vitiligo. (external link)
• Bergithe Eikeland Oftedal; Nicolas Delaleu; David William Peter Dolan et al. (2023). Systemic interferon type I and B cell responses are impaired in autoimmune polyendocrine syndrome type 1. (external link)
• Felix Beuschlein; Tobias Else; Irina Bancos et al. (2024). European Society of Endocrinology and Endocrine Society Joint Clinical Guideline: Diagnosis and therapy of glucocorticoid-induced adrenal insufficiency. (external link)
• Anette Susanne Bøe Wolff; Jaanika Kärner; Jone Furulund Owe et al. (2014). Clinical and serologic parallels to APS-I in patients with thymomas and autoantigen transcripts in their tumors. (external link)
• Øyvind Bruserud; Eystein Sverre Husebye (2015). En mann i 30-årene med diabetes og vitiligo.. (external link)
• Mohammad Alimohammadi; Peyman Björklund; Åsa Hallgren et al. (2008). Autoimmune polyendocrine syndrome type 1 and NALP5, parathyroid autoantigen. (external link)
• Martina Moter Erichsen; Martina M Erichsen; Kristian Løvås et al. (2009). Clinical, Immunological, and Genetic Features of Autoimmune Primary Adrenal Insufficiency: Observations from a Norwegian Registry. (external link)
• Kristian Løvås; Jon Håvard Loge; Eystein Husebye (2002). Subjective health status in Norwegian patients with Addison's disease. (external link)
• Maria Halonen; Petra Bjørses; Anne Grethe Myhre et al. (2002). Autoimmune Regulator and Human Leucocyte Antigen Genotypes as Determinants of the Autoimmune Polyendocrinopathy-Candidiasis-Ectodermal Dystrophy Phenotype. (external link)
• Geir Bredholt; Anette Margrethe Storstein; Monica Haugen et al. (2006). Detection of autoantibodies to the BTB-kelch protein KLHL7 in cancer sera. (external link)
• Eirik Bratland; Ng'weina Francis Magitta; Anette Susanne Bøe Wolff et al. (2013). Autoantibodies against aromatic amino acid hydroxylases in patients with autoimmune polyendocrine syndrome type 1 target multiple antigenic determinants and reveal regulatory regions crucial for enzymatic activity. (external link)
• Ingrid Nermoen; Ingeborg Brønstad; Kristian J Fougner et al. (2012). Genetic, anthropometric and metabolic features of adult Norwegian patients with 21-hydroxylase deficiency. (external link)
• shahinul islam; Bergithe Eikeland Oftedal; Miriam Gjerdevik et al. (2025). Immune cell subsets in autoimmune polyendocrine syndrome type I. (external link)
• Kristian Løvås; Eystein Husebye (2003). Replacement therapy in Addison's disease. (external link)
• Kristian Løvås; J.G. Cooper; T. Thorsen et al. (2003). Døgnrytme til besvær. (external link)
• Anette Susanne Bøe Wolff; Martina Moter Erichsen; Anthony Meager et al. (2007). Autoimmune polyendocrine syndrome type 1 in Norway: Phenotypic variation, autoantibodies, and novel mutations in the autoimmune regulator gene. (external link)
• S Gebre-Medhin; Eystein Husebye; H Mallmin et al. (2000). Oral dehydroepiandrosterone (DHEA) replacement therapy in women with Addison's disease. (external link)
• Jan Inge Sørheim; Eystein Sverre Husebye; Bjørn Gunnar Nedrebø et al. (2010). Phenotypic Variation in a Large Family with Autosomal Dominant Hypocalcaemia. (external link)
• Bergithe Eikeland Oftedal; Olle Kämpe; Anthony Meager et al. (2011). Measuring autoantibodies against IL-17F and IL-22 in Autoimmune Polyendocrine Syndrome Type I by radioligand binding assay using fusion proteins. (external link)
• Åse Bjorvatn Sævik; Grethe Åstrøm Ueland; Anna-Karin Åkerman et al. (2023). Altered biomarkers for cardiovascular disease and inflammation in autoimmune Addison's disease - a cross-sectional study. (external link)
• Anna L. Mitchell; Katie D.R. Macarthur; Earn H. Gan et al. (2014). Association of autoimmune Addison's disease with alleles of STAT4 and GATA3 in European Cohorts. (external link)
• Haalen van Haalen; M. Kaya; I.C.M. Pelsma et al. (2022). Current clinical practice for thromboprophylaxis management in patients with Cushing’s syndrome across reference centers of the European Reference Network on Rare Endocrine Conditions (Endo-ERN). (external link)
• Eystein Sverre Husebye; Frederik Castinetti; Sherwin Criseno et al. (2022). Endocrine-related adverse conditions in patients receiving immune checkpoint inhibition: an ESE clinical practice guideline. (external link)
• Thomas J. Upton; Eder Zavala; Paal Methlie et al. (2023). High-resolution daily profiles of tissue adrenal steroids by portable automated collection. (external link)
• Eystein Sverre Husebye; Jaakko Perheentupa; Riina Rautemaa et al. (2009). Clinical manifestations and management of patients with autoimmune polyendocrine syndrome type I. (external link)
• Liv Hapnes; Nick Willcox; Bergithe Eikeland Oftedal et al. (2012). Radioligand-binding assay reveals distinct autoantibody preferences for type I interferons in APS I and myasthenia gravis subgroups. (external link)
• Beata Toth; Anette Susanne Bøe Wolff; Zita Halász et al. (2010). Novel sequence variation of AIRE and detection of interferon-ω antibodies in early infancy. (external link)
• D. Astuti; F. Latif; A. Dallol et al. (2001). Gene mutations in the succinate dehydrogenase subunit SDHB cause susceptibility to familial pheochromocytoma and to familial paraganglioma. (external link)
• Håkan Hedstrand; Olov Ekwall; Mats J. Olsson et al. (2001). The transcription factors SOX9 and SOX10 are vitiligo autoantigens in autoimmune polyendocrine syndrome type I. (external link)
• Eystein S.Junior Husebye; Sylvi Aanderud (1998). Primær binyrebarksvikt - en diagnostisk utfordring. (external link)
• Anette Susanne Bøe; Geir Bredholt; Per Knappskog et al. (2004). Autoantibodies against 21-hydroxylase and side-chain cleavage enzyme in autoimmune Addison's disease are mainly immunoglobulin G1. (external link)
• Beate Skinningsrud; Eystein Sverre Husebye; Kristina Gervin et al. (2008). Mutation screening of PTPN22: association of the 1858T-allele with Addison's disease. (external link)
• Bergithe Eikeland Oftedal; Alexander Hellesen; Martina Moter Erichsen et al. (2015). Dominant mutations in the autoimmune regulator AIRE are associated with common organ-specific autoimmune diseases. (external link)
• Elizaveta M. Orlova; Leila S. Sozaeva; Maria A. Kareva et al. (2017). Expanding the Phenotypic and Genotypic Landscape of Autoimmune Polyendocrine Syndrome Type 1.. (external link)
• Olov Ekwall; Håkan Hedstrand; Jan Haavik et al. (2000). Pteridine-dependent hydroxylases as autoantigens in autoimmune polyendocrine syndrome type 1. (external link)
• Marianne Aardal Grytaas; Siri S. Strømsøy; Jarle Rørvik et al. (2017). Clinical Characteristics and Long-Term Outcome of Primary Aldosteronism in a Norwegian Population. (external link)
• Eystein Sverre Husebye; Kristian Løvås (2009). Pathogenesis of primary adrenal insufficiency. (external link)
• Sandra Rinne Dahl; Ingrid Nermoen; Ingeborg Brønstad et al. (2018). Assay of steroids by liquid chromatography-tandem mass spectrometry in monitoring 21-hydroxylase deficiency.. (external link)
• Hanna Nowotny; Uta Neumann; Veronique Tardy-Guidollet et al. (2022). Prenatal dexamethasone treatment for classic 21-hydroxylase deficiency in Europe. (external link)
• Grethe Åstrøm Ueland; Paal Methlie; Anette Heie et al. (2023). Substantial changes in inflammatory and cardiovascular biomarkers in patients with autonomous cortisol secretion. (external link)
• Paul Bastard; Adrian Gervais; Tom Le Voyer et al. (2021). Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths. (external link)
• Dmytro Fishman; Kai Kisand; Christina Hertel et al. (2017). Autoantibody repertoire in APECED patients targets two distinct subgroups of proteins. (external link)
• Nils Landegren; Mina Pourmousa Lindberg; Jakob Skov et al. (2016). Autoantibodies targeting a collecting duct-specific water channel in tubulointerstitial nephritis. (external link)
• HH Hedstrand; O Ekwall; Jan Haavik et al. (2000). Identification of tyrosine hydroxylase as an autoantigen in autoimmune polyendocrine syndrome type I. (external link)
• Marissa Penna-Martinez; Natalie Filmann; Dimitra Bogdanou et al. (2018). High-dose vitamin D in Addison's disease regulates T-cells and monocytes: A pilot trial. (external link)
• Trine Elholm Bjånesøy; Bettina Kulle; Eirik Bratland et al. (2014). Altered DNA methylation profile in Norwegian patients with Autoimmune Addison's Disease. (external link)
• Amina Dawoodji; Ji-Li Chen; Dawn Shepherd et al. (2014). High frequency of cytolytic 21-hydroxylase-specific CD8+ T cells in autoimmune Addison's disease patients. (external link)
• Nils Landegren; Donald Sharon; Anthony K. Shum et al. (2015). Transglutaminase 4 as a prostate autoantigen in male subfertility. (external link)
• Grethe Åstrøm Ueland; Paal Methlie; Ralf Kellmann et al. (2017). Simultaneous assay of cortisol and dexamethasone improved diagnostic accuracy of the dexamethasone suppression test. (external link)
• Marianne Astor; Kristian Løvås; Aleksandra Debowska et al. (2016). Epidemiology and health-related quality of life in hypoparathyroidism in Norway. (external link)
• Thea Sjøgren; shahinul islam; Igor Filippov et al. (2024). Single cell characterization of blood and expanded regulatory T cells in autoimmune polyendocrine syndrome type 1. (external link)
• G Gebre-Medhin; Eystein S.Junior Husebye; F Rorsman et al. (1997). Cytochrome P450IA2 and aromatic L-amino acid decarboxylase are hepatic autoantigens in autoimmune polyendocrine syndrome type I. (external link)
• L.S. Sozaeva; E.M. Orlova; Bergithe Eikeland Oftedal et al. (2016). Antibodies against NALP5 and it's role in hypoparathyroidism in autoimmune polyglandular syndrome type 1. (external link)
• Mads Aarhus; Ove Bruland; Geir Bredholt et al. (2008). Microarray analysis reveals down-regulation of the tumour suppressor gene WWOX and up-regulation of the oncogene TYMS in intracranial sporadic meningiomas. (external link)
• Kristian Løvås; Thor Elias Thorsen; Eystein S.Junior Husebye (2006). Saliva cortisol measurement: simple and reliable assessment of the glucocorticoid replacement therapy in Addison's disease. (external link)
• Anette Susanne Bøe Wolff; Bergithe Eikeland Oftedal; Stefan Johansson et al. (2008). AIRE variations in Addison's disease and autoimmune polyendocrine syndromes (APS): partial gene deletions contribute to APS I. (external link)
• Elinor Margrethe Chelsom Vogt; Katrin Hammerling; Halfdan Sorbye et al. (2021). Feminizing adrenal tumor identified by plasma steroid profiling. (external link)
• Petter Schandl Sanaker; Eystein S.Junior Husebye; Ove Fondenes et al. (2007). Clinical evolution of Kearns-Sayre syndrome with polyendocrinopathy and respiratory failure. (external link)
• Amund Holte Berger; Bergithe Eikeland Oftedal; Anette Susanne Bøe Wolff et al. (2025). High-resolution transcriptional impact of AIRE: effects of pathogenic variants p.Arg257Ter, p.Cys311Tyr, and polygenic risk variant p.Arg471Cys. (external link)
• Anthony Meager; Kumuthini Visvalingam; Pärt Peterson et al. (2006). Anti-interferon autoantibodies in autoimmune polyendocrinopathy syndrome type 1. (external link)
• Øyvind Bruserud; Bergithe Eikeland Oftedal; Nils Landegren et al. (2016). A longitudinal follow-up of autoimmune polyendocrine syndrome type 1. (external link)
• Beate Skinningsrud; Benedicte Alexandra Lie; Eystein Husebye et al. (2009). A CLEC16A variant confers risk for juvenile idiopathic arthritis and anti-CCP negative rheumatoid arthritis. (external link)
• Marianne Grytaas; Kjersti Sellevåg; Hrafnkell B Thordarson et al. (2018). Cardiac magnetic resonance imaging of myocardial mass and fibrosis in primary aldosteronism. (external link)
• Hans Olav Ueland; Grethe Åstrøm Ueland; Kristian Løvås et al. (2022). Novel inflammatory biomarkers in thyroid eye disease. (external link)
• Marianne Øksnes; Eystein Sverre Husebye (2023). Approach to the Patient: Diagnosis of Primary Adrenal Insufficiency in Adults. (external link)
• Filip Sköldberg; Guida M. Portela-Gomes; Lars Grimelius et al. (2003). Histidine decarboxylase, a pyridoxal phosphate-dependent enzyme, is an autoantigen of gastric enterochromaffin-like cells. (external link)
• Paul Bastard; Adrian Gervais; Maki Taniguchi et al. (2024). Higher COVID-19 pneumonia risk associated with anti-IFN-α than with anti-IFN-ω auto-Abs in children. (external link)
• A Søderbergh; F Rorsman; M Halonen et al. (2000). Autoantibodies against aromatic L-amino acid decarboxylase delineate a subgroup of patients with Addison's disease. (external link)
• Jan Dobeš; Osher Ben-Nun; Amit Binyamin et al. (2022). Extrathymic expression of Aire controls the induction of effective T<inf>H</inf>17 cell-mediated immune response to Candida albicans. (external link)
• Eystein Sverre Husebye; Bruno Allolio; Wiebke Arlt et al. (2014). Consensus statement on the diagnosis, treatment and follow-up of patients with primary adrenal insufficiency. (external link)
• Eystein S.Junior Husebye; Zev M. Sthoeger; Molly Dayan et al. (2005). Autoantibodies to a NR2A peptide of the glutamate/NMDA receptor in sera of patients with systemic lupus erythematosus. (external link)
• Eystein Sverre Husebye; Bruno Allolio; Wiebke Arlt et al. (2014). Consensus statement on the diagnosis, treatment and follow-up of patients with primary adrenal insufficiency. (external link)
• Eystein S.Junior Husebye; Zev M. Sthoeger; Molly Dayan et al. (2005). Autoantibodies to a NR2A peptide of the glutamate/NMDA receptor in sera of patients with systemic lupus erythematosus. (external link)
• Elinor Margrethe Chelsom Vogt; Lars Ertesvåg Breivik; Ellen Christine Røyrvik et al. (2021). Primary ovarian insufficiency in women with Addison's disease. (external link)
• Grethe Åstrøm Ueland; Paal Methlie; Marianne Øksnes et al. (2018). The short cosyntropin test revisited: new normal reference range using LC-MS/MS. (external link)
• Anne Blomhoff; Helen Kemp; David J. Gawkrodger et al. (2005). CTLA4 polymorphisms are associated with vitiligo, in patients with concomitant autoimmune diseases. (external link)
• Ng'weina Francis Magitta; Mikulás Pura; Anette Susanne Bøe Wolff et al. (2008). Autoimmune polyendocrine syndrome type I in Slovakia: relevance of screening patients with autoimmune Addison's disease. (external link)
• Beate Skinningsrud; Benedicte Alexandra Lie; Ewa Lavant et al. (2011). Multiple loci in the HLA complex are associated with Addison's Disease. (external link)
• Anette Susanne Bøe Wolff; Lena Hansen; Marianne Aardal Grytaas et al. (2023). Vaccination prevents severe COVID-19 outcome in patients with neutralizing type 1 interferon autoantibodies. (external link)
• Yael Gruper; Anette Susanne Bøe Wolff; Liad Glanz et al. (2023). Autoimmune amelogenesis imperfecta in patients with APS-1 and coeliac disease. (external link)
• Eirik Bratland; B Skinningsrud; Dag Erik Undlien et al. (2009). T Cell Responses to Steroid Cytochrome P450 21-Hydroxylase in Patients with Autoimmune Primary Adrenal Insufficiency. (external link)
• Marianne Øksnes; Sigridur Björnsdottir; Magnus Isaksson et al. (2014). Continuous subcutaneous hydrocortisone infusion versus oral hydrocortisone replacement for treatment of Addison's disease: A randomized clinical trial. (external link)
• Anette Susanne Bøe Wolff; Kjell-Morten Myhr; Christian A. Vedeler et al. (2007). Fc gamma receptor polymorphisms are not associated with autoimmune Addison's disease. (external link)
• Ingrid Nermoen; Jarle Rørvik; Stein Harald Holmedal et al. (2011). High frequency of adrenal myelolipomas and testicular adrenal rest tumours in adult Norwegian patients with classical congenital adrenal hyperplasia because of 21-hydroxylase deficiency. (external link)
• Bergithe Eikeland Oftedal; Anette Susanne Bøe Wolff; Eirik Bratland et al. (2008). Radioimmunoassay for autoantibodies against interferon omega; its use in the diagnosis of autoimmune polyendocrine syndrome type I. (external link)
• O Ekwall; H.H. Hedstrand; L Grimelius et al. (1998). Identification of tryptophan hydroxylase as an intestinal autoantigen. (external link)
• Nora Møller Didriksen; Åse Bjorvatn Sævik; Linn Solveig Sortland et al. (2021). Sex-Specific Limitations in Physical Health in Primary Adrenal Insufficiency. (external link)
• F. Skoldberg; F. Rorsman; J. Perheentupa et al. (2004). Analysis of antibody reactivity against cysteine sulfinic acid decarboxylase, a pyridoxal phosphate-dependent enzyme, in endocrine autoimmune disease. (external link)
• Svetlana Vakkilainen; Riikka Makitie; Paula Klemetti et al. (2018). A wide spectrum of autoimmune manifestations and other symptoms suggesting immune dysregulation in patients with cartilage-hair hypoplasia. (external link)
• Anne Blomhoff; Benedicte a. Lie; A.G. Myhre et al. (2004). Polymorphisms in the cytotoxic T lymphocyte antigen-4 gene region confer susceptibility to Addison's disease. (external link)
• Sigrid Aslaksen; Paal Methlie; Magnus Dehli Vigeland et al. (2019). Coexistence of congenital adrenal hyperplasia and autoimmune Addison's disease. (external link)
• Kine Susann Waade Edvardsen; Trine Elholm Bjånesøy; Alexander Hellesen et al. (2015). Peripheral blood cells from patients with autoimmune Addison's disease poorly respond to interferons in vitro, despite elevated serum levels of interferon-inducible chemokines. (external link)
• Alberto Falorni; Vittorio Bini; Corrado Betterle et al. (2015). Determination of 21-hydroxylase autoantibodies: Inter-laboratory concordance in the Euradrenal International Serum Exchange Program. (external link)
• Martina Moter Erichsen; Martina M Erichsen; K Lovas et al. (2009). Normal overall mortality rate in Addison's disease, but young patients are at risk of premature death. (external link)
• Bergithe Eikeland Oftedal; Kristian Assing; Safa Baris et al. (2023). Dominant-negative heterozygous mutations in AIRE confer diverse autoimmune phenotypes. (external link)
• Paul Bastard; Elizaveta Orlova; Leila S. Sozaeva et al. (2021). Preexisting autoantibodies to type I IFNs underlie critical COVID-19 pneumonia in patients with APS-1. (external link)
• Eystein S.Junior Husebye; Anette Susanne Bøe; F Rorsman et al. (2000). Inhibition of aromatic 1-amino acid decarboxylase by human autoantibodies. (external link)
• A Søderbergh; F Rorsman; M Halonen et al. (2000). Autoantibodies against aromatic L-amino acid decarboxylase delineate a subgroup of patients with Addison's disease. (external link)
• Marianne Øksnes; Sophie Bensing; Anna-Lena Hulting et al. (2012). Quality of life in European patients with Addison's Disease: Validity of the disease-specific questionnaire AddiQoL. (external link)
• Kristian Løvås; Eystein S.Junior Husebye (2007). Continuous subcutaneous hydrocortisone infusion in Addison's disease. (external link)
• Isil Kucuka; Dorsa Iraji; Sarah Braun et al. (2025). Longitudinal Immune Profiling in Autoimmune Polyendocrine Syndrome Type 1. (external link)
• Kristian Løvås; Thor S Trovik; Kristian J Fougner et al. (2003). Replacement of Dehydroepiandrosterone in Adrenal Failure: No Benefit for Subjective Healt Status and Sexuality in a 9-Month, Randomized, Parallel Group Clinical Trial. (external link)
• Anette Susanne Bøe Wolff; Bergithe Eikeland Oftedal; Kai Kisand et al. (2010). Flow cytometry study of blood cell subtypes reflects autoimmune and inflammatory processes in autoimmune polyendocrine syndrome type I. (external link)
• Guri Fossdal; Peder Rustøen Braadland; Johannes Espolin Roksund Hov et al. (2025). Mitochondrial dysfunction and lipid alterations in primary sclerosing cholangitis. (external link)
• Alessandro Prete; Anuradhaa Subramanian; Irina Bancos et al. (2022). Cardiometabolic Disease Burden and Steroid Excretion in Benign Adrenal Tumors A Cross-Sectional Multicenter Study. (external link)
• Kristian Løvås; K Lovas; Therese Halvorsen Røst et al. (2009). Tetradecylthioacetic acid attenuates dyslipidaemia in male patients with type 2 diabetes mellitus, possibly by dual PPAR-alpha/delta activation and increased mitochondrial fatty acid oxidation. (external link)
• Kristian Løvås; Clara G Gjesdal; Monica Christensen et al. (2009). Glucocorticoid replacement therapy and pharmacogenetics in Addison's disease: effects on bone. (external link)
• Antonella Meloni; Nick Willcox; Anthony Meager et al. (2012). Autoimmune polyendocrine syndrome Type 1: an Eetensive longitudinal study in Sardinian patients. (external link)
• Muhammad Rahman; André Sulen; Lars Ertesvåg Breivik et al. (2025). Anti-perilipin-1 autoantibodies in autoimmune Addison’s disease and related endocrine disorders. (external link)
• Alexander Hellesen; Sigrid Aslaksen; Lars Ertesvåg Breivik et al. (2021). 21-Hydroxylase-Specific CD8+ T Cells in Autoimmune Addison’s Disease Are Restricted by HLA-A2 and HLA-C7 Molecules. (external link)
• Marta Fichna; Magdalena Zurawek; Eirik Bratland et al. (2015). Interleukin-2 and subunit alpha of its soluble receptor in autoimmune Addison's disease - An association study and expression analysis. (external link)
• Grethe Åstrøm Ueland; Ralf Kellmann; Melissa Davidsen Jørstad et al. (2021). Bedtime Salivary Cortisol as a Screening Test for Cushing Syndrome in Children. (external link)
• Sigridur Björnsdottir; Marianne Øksnes; Magnus Isaksson et al. (2015). Circadian hormone profiles and insulin sensitivity in patients with Addison's disease: a comparison of continuous subcutaneous hydrocortisone infusion with conventional glucocorticoid replacement therapy. (external link)
• Anthony K. Shum; Mohammad Alimohammadi; Catherie L. Tan et al. (2013). BPIFB1 is a lung-specific autoantigen associated with interstitial lung disease. (external link)
• Anne Grethe Myhre; Dag Erik Undlien; Kristian Løvås et al. (2002). Autoimmune adrenocortical failure in Norway. Autoantibodies and HLA class II associations related to clinical features. (external link)
• Bjørn G Nedrebø; Pål Ivar Holm; Sverre Uhlving et al. (2002). Predictors of outcome and comparison of different drug regimens for the prevention of relapse in patients with Graves' disease. (external link)
• Katerina Simunkova; Nevena Jovanovic; Espen Rostrup et al. (2016). Effect of a pre-exercise hydrocortisone dose on short-term physical performance in female patients with primary adrenal failure. (external link)
• Kristian Løvås; Suzanne Curran; Marianne Øksnes et al. (2009). Development of a Disease-Specific Quality of Life Questionnaire in Addison’s Disease. (external link)
• shahinul islam; Bergithe Eikeland Oftedal; Miriam Gjerdevik et al. (2025). Immune cell subsets in autoimmune polyendocrine syndrome type I. (external link)
• Kristian Løvås; Eystein Husebye (2003). Replacement therapy in Addison's disease. (external link)
• Kristian Løvås; J.G. Cooper; T. Thorsen et al. (2003). Døgnrytme til besvær. (external link)
• Anette Susanne Bøe Wolff; Martina Moter Erichsen; Anthony Meager et al. (2007). Autoimmune polyendocrine syndrome type 1 in Norway: Phenotypic variation, autoantibodies, and novel mutations in the autoimmune regulator gene. (external link)
• S Gebre-Medhin; Eystein Husebye; H Mallmin et al. (2000). Oral dehydroepiandrosterone (DHEA) replacement therapy in women with Addison's disease. (external link)
• Jan Inge Sørheim; Eystein Sverre Husebye; Bjørn Gunnar Nedrebø et al. (2010). Phenotypic Variation in a Large Family with Autosomal Dominant Hypocalcaemia. (external link)
• Bergithe Eikeland Oftedal; Olle Kämpe; Anthony Meager et al. (2011). Measuring autoantibodies against IL-17F and IL-22 in Autoimmune Polyendocrine Syndrome Type I by radioligand binding assay using fusion proteins. (external link)
• Åse Bjorvatn Sævik; Grethe Åstrøm Ueland; Anna-Karin Åkerman et al. (2023). Altered biomarkers for cardiovascular disease and inflammation in autoimmune Addison's disease - a cross-sectional study. (external link)
• Anna L. Mitchell; Katie D.R. Macarthur; Earn H. Gan et al. (2014). Association of autoimmune Addison's disease with alleles of STAT4 and GATA3 in European Cohorts. (external link)
• Haalen van Haalen; M. Kaya; I.C.M. Pelsma et al. (2022). Current clinical practice for thromboprophylaxis management in patients with Cushing’s syndrome across reference centers of the European Reference Network on Rare Endocrine Conditions (Endo-ERN). (external link)
• Eystein Sverre Husebye; Frederik Castinetti; Sherwin Criseno et al. (2022). Endocrine-related adverse conditions in patients receiving immune checkpoint inhibition: an ESE clinical practice guideline. (external link)
• Thomas J. Upton; Eder Zavala; Paal Methlie et al. (2023). High-resolution daily profiles of tissue adrenal steroids by portable automated collection. (external link)
• Eystein Sverre Husebye; Jaakko Perheentupa; Riina Rautemaa et al. (2009). Clinical manifestations and management of patients with autoimmune polyendocrine syndrome type I. (external link)
• Liv Hapnes; Nick Willcox; Bergithe Eikeland Oftedal et al. (2012). Radioligand-binding assay reveals distinct autoantibody preferences for type I interferons in APS I and myasthenia gravis subgroups. (external link)
• Beata Toth; Anette Susanne Bøe Wolff; Zita Halász et al. (2010). Novel sequence variation of AIRE and detection of interferon-ω antibodies in early infancy. (external link)
• D. Astuti; F. Latif; A. Dallol et al. (2001). Gene mutations in the succinate dehydrogenase subunit SDHB cause susceptibility to familial pheochromocytoma and to familial paraganglioma. (external link)
• Håkan Hedstrand; Olov Ekwall; Mats J. Olsson et al. (2001). The transcription factors SOX9 and SOX10 are vitiligo autoantigens in autoimmune polyendocrine syndrome type I. (external link)
• Eystein S.Junior Husebye; Sylvi Aanderud (1998). Primær binyrebarksvikt - en diagnostisk utfordring. (external link)
• Anette Susanne Bøe; Geir Bredholt; Per Knappskog et al. (2004). Autoantibodies against 21-hydroxylase and side-chain cleavage enzyme in autoimmune Addison's disease are mainly immunoglobulin G1. (external link)
• Beate Skinningsrud; Eystein Sverre Husebye; Kristina Gervin et al. (2008). Mutation screening of PTPN22: association of the 1858T-allele with Addison's disease. (external link)
• Bergithe Eikeland Oftedal; Alexander Hellesen; Martina Moter Erichsen et al. (2015). Dominant mutations in the autoimmune regulator AIRE are associated with common organ-specific autoimmune diseases. (external link)
• Elizaveta M. Orlova; Leila S. Sozaeva; Maria A. Kareva et al. (2017). Expanding the Phenotypic and Genotypic Landscape of Autoimmune Polyendocrine Syndrome Type 1.. (external link)
• Olov Ekwall; Håkan Hedstrand; Jan Haavik et al. (2000). Pteridine-dependent hydroxylases as autoantigens in autoimmune polyendocrine syndrome type 1. (external link)
• Marianne Aardal Grytaas; Siri S. Strømsøy; Jarle Rørvik et al. (2017). Clinical Characteristics and Long-Term Outcome of Primary Aldosteronism in a Norwegian Population. (external link)
• Eystein Sverre Husebye; Kristian Løvås (2009). Pathogenesis of primary adrenal insufficiency. (external link)
• Sandra Rinne Dahl; Ingrid Nermoen; Ingeborg Brønstad et al. (2018). Assay of steroids by liquid chromatography-tandem mass spectrometry in monitoring 21-hydroxylase deficiency.. (external link)
• Martina Moter Erichsen; Martina M Erichsen; K Lovas et al. (2009). Normal overall mortality rate in Addison's disease, but young patients are at risk of premature death. (external link)
• Bergithe Eikeland Oftedal; Kristian Assing; Safa Baris et al. (2023). Dominant-negative heterozygous mutations in AIRE confer diverse autoimmune phenotypes. (external link)
• Paul Bastard; Elizaveta Orlova; Leila S. Sozaeva et al. (2021). Preexisting autoantibodies to type I IFNs underlie critical COVID-19 pneumonia in patients with APS-1. (external link)
• Eystein S.Junior Husebye; Anette Susanne Bøe; F Rorsman et al. (2000). Inhibition of aromatic 1-amino acid decarboxylase by human autoantibodies. (external link)
• A Søderbergh; F Rorsman; M Halonen et al. (2000). Autoantibodies against aromatic L-amino acid decarboxylase delineate a subgroup of patients with Addison's disease. (external link)
• Marianne Øksnes; Sophie Bensing; Anna-Lena Hulting et al. (2012). Quality of life in European patients with Addison's Disease: Validity of the disease-specific questionnaire AddiQoL. (external link)
• Kristian Løvås; Eystein S.Junior Husebye (2007). Continuous subcutaneous hydrocortisone infusion in Addison's disease. (external link)
• Isil Kucuka; Dorsa Iraji; Sarah Braun et al. (2025). Longitudinal Immune Profiling in Autoimmune Polyendocrine Syndrome Type 1. (external link)
• Kristian Løvås; Thor S Trovik; Kristian J Fougner et al. (2003). Replacement of Dehydroepiandrosterone in Adrenal Failure: No Benefit for Subjective Healt Status and Sexuality in a 9-Month, Randomized, Parallel Group Clinical Trial. (external link)
• Anette Susanne Bøe Wolff; Bergithe Eikeland Oftedal; Kai Kisand et al. (2010). Flow cytometry study of blood cell subtypes reflects autoimmune and inflammatory processes in autoimmune polyendocrine syndrome type I. (external link)
• Guri Fossdal; Peder Rustøen Braadland; Johannes Espolin Roksund Hov et al. (2025). Mitochondrial dysfunction and lipid alterations in primary sclerosing cholangitis. (external link)
• Alessandro Prete; Anuradhaa Subramanian; Irina Bancos et al. (2022). Cardiometabolic Disease Burden and Steroid Excretion in Benign Adrenal Tumors A Cross-Sectional Multicenter Study. (external link)
• Kristian Løvås; K Lovas; Therese Halvorsen Røst et al. (2009). Tetradecylthioacetic acid attenuates dyslipidaemia in male patients with type 2 diabetes mellitus, possibly by dual PPAR-alpha/delta activation and increased mitochondrial fatty acid oxidation. (external link)
• Kristian Løvås; Clara G Gjesdal; Monica Christensen et al. (2009). Glucocorticoid replacement therapy and pharmacogenetics in Addison's disease: effects on bone. (external link)
• Antonella Meloni; Nick Willcox; Anthony Meager et al. (2012). Autoimmune polyendocrine syndrome Type 1: an Eetensive longitudinal study in Sardinian patients. (external link)
• Muhammad Rahman; André Sulen; Lars Ertesvåg Breivik et al. (2025). Anti-perilipin-1 autoantibodies in autoimmune Addison’s disease and related endocrine disorders. (external link)
• Alexander Hellesen; Sigrid Aslaksen; Lars Ertesvåg Breivik et al. (2021). 21-Hydroxylase-Specific CD8+ T Cells in Autoimmune Addison’s Disease Are Restricted by HLA-A2 and HLA-C7 Molecules. (external link)
• Marta Fichna; Magdalena Zurawek; Eirik Bratland et al. (2015). Interleukin-2 and subunit alpha of its soluble receptor in autoimmune Addison's disease - An association study and expression analysis. (external link)
• Grethe Åstrøm Ueland; Ralf Kellmann; Melissa Davidsen Jørstad et al. (2021). Bedtime Salivary Cortisol as a Screening Test for Cushing Syndrome in Children. (external link)
• Sigridur Björnsdottir; Marianne Øksnes; Magnus Isaksson et al. (2015). Circadian hormone profiles and insulin sensitivity in patients with Addison's disease: a comparison of continuous subcutaneous hydrocortisone infusion with conventional glucocorticoid replacement therapy. (external link)
• Anthony K. Shum; Mohammad Alimohammadi; Catherie L. Tan et al. (2013). BPIFB1 is a lung-specific autoantigen associated with interstitial lung disease. (external link)
• Anne Grethe Myhre; Dag Erik Undlien; Kristian Løvås et al. (2002). Autoimmune adrenocortical failure in Norway. Autoantibodies and HLA class II associations related to clinical features. (external link)
• Bjørn G Nedrebø; Pål Ivar Holm; Sverre Uhlving et al. (2002). Predictors of outcome and comparison of different drug regimens for the prevention of relapse in patients with Graves' disease. (external link)
• Katerina Simunkova; Nevena Jovanovic; Espen Rostrup et al. (2016). Effect of a pre-exercise hydrocortisone dose on short-term physical performance in female patients with primary adrenal failure. (external link)
• Kristian Løvås; Suzanne Curran; Marianne Øksnes et al. (2009). Development of a Disease-Specific Quality of Life Questionnaire in Addison’s Disease. (external link)

Conference lecture

• Eystein Husebye (2002). Autoimmune polyendocrine syndromes. (external link)
• T Rygh; Eystein S.Junior Husebye (1997). Ductal autoantigens in Sjøgren's syndrome. (external link)
• Eystein Husebye (2002). Pituitary tumours in multiple endocrine neoplasia type 1. (external link)
• Anne Grethe Myhre; Eystein Husebye; Dag E. Undlien et al. (2002). Høy forekomst av cøliaci hos pasienter med autoimmun binyrebarksvikt. (external link)
• Anne Grethe Myhre; Eystein Husebye; Dag E. Undlien (2001). Autoimmun primær binyrebarksvikt i Norge. Autoantistoffer og HLA klasse II assosiasjoner relatert til kliniske manifestasjoner. (external link)
• Eystein Husebye (2003). Autoimmune Addisons disease and polyendocrine syndromes. (external link)
• D Hammenfors; Kristian Løvås; G Bredholt et al. (2005). Variable expression of FKBP51 in Addison's Disease - a parameter of glucocorticoid sensitivity ?. (external link)
• Eystein Husebye (2001). Klinisk handläggning av APS I patienter. (external link)
• M Pura; M Straka; D Felcanová et al. (2005). Ganglioneuroma in patient with adrenal insufficiency - rare coincidence of adrenal cortex and medulla disorders. (external link)
• M Pura; A Pelet; M Grófik et al. (2005). Severe neurological impairment in patient with allgrove syndrome caused by frame shift mutation G363X (1066-1067delCT) and novel missense mutation W272S (TGG->TCG). (external link)
• Anne Grethe Myhre; Eystein Husebye; Dag E. Undlien et al. (2002). Høy forekomst av cøliaci hos pasienter med autoimmun binyrebarksvikt. (external link)
• Anne Grethe Myhre; Eystein Husebye; Dag E. Undlien (2001). Autoimmun primær binyrebarksvikt i Norge. Autoantistoffer og HLA klasse II assosiasjoner relatert til kliniske manifestasjoner. (external link)
• M Pura; M Straka; D Felcanová et al. (2005). Ganglioneuroma in patient with adrenal insufficiency - rare coincidence of adrenal cortex and medulla disorders. (external link)
• M Pura; A Pelet; M Grófik et al. (2005). Severe neurological impairment in patient with allgrove syndrome caused by frame shift mutation G363X (1066-1067delCT) and novel missense mutation W272S (TGG->TCG). (external link)

Conference poster

• Anette Susanne Bøe; Ola Winqvist; Per Morten Knappskog et al. (2002). Autoantibodies Against SCC in Addison`s Disease, APS I and in APS II Are Mainly IgG1. (external link)
• Anne Grethe Myhre; Hildegunn Årsetøy; Dag Erik Undlien et al. (2002). High frequency of celiac disease among patients with autoimmune adrenocortical failure. (external link)
• Anette Susanne Bøe; Geir Bredholt; Christian A Vedeler et al. (2003). Identification of a novel paraneoplastic autoantigen with phosphatase- and hydrolase-like domains in the central nervous system. (external link)
• Kristian Løvås; Jon Håvard Loge; Eystein Husebye (2001). Quality of life in Norwegian patients with Addison's disease. (external link)
• Lars Ertesvåg Breivik; Bergithe Eikeland Oftedal; Eirik Bratland et al. (2013). A novel cell-based assay for measuring neutralizing autoantibodies against type I interferons in patients with APS-1. (external link)
• Ileana Mihaela Cuida Marthinussen; Martina Moter Erichsen; Malin V Jonsson et al. (2011). Oral Manifestations of Autoimmune PolyendocrineSyndrome Type I. (external link)
• Morten Christoph Eike; Beate Skinningsrud; Benedicte Alexandra Lie et al. (2011). No association with RFX, CCR5 or CD226 polymorphisms in Norwegian Addison’s disease patients. (external link)
• Anne Grethe Myhre; Asbjørg Stray-Pedersen; Eigill Eide et al. (2002). Primary hypothyroidism and chronic mucocutaneous candidiasis in three siblings. (external link)
• Kristian Løvås; Thor Thorsen; Eystein Husebye (2003). Salivary cortisol measurement in the assessment of the glucocorticoid replacement therapy in Addison's disease. (external link)
• Kristian Løvås; Jon Håvard Loge; Eystein Husebye (2001). Quality of life in Norwegian patients with Addison's disease. (external link)

Conference abstract

• Paal Methlie; Kristian Løvås; Ernst Asbjørn Lien et al. (2010). Grapefruit and Liquorice Increase Bioavailable Cortisol in Addison's Disease. (external link)
• Bergithe Eikeland Oftedal; Martina Moter Erichsen; Alexander Hellesen et al. (2013). Dominant Inheritance in Autoimmune Endocrine Syndrome Type 1. (external link)
• Åsa Hallgren; Mina Pourmousa; Jakob Skov et al. (2010). Immunoreactivity against kidney collecting ducts in patients with autoimmune polyendocrine syndrome type 1 and systemic hypertension. (external link)
• M Cheng; M Barnes; A Mehta et al. (2009). Loss of AIRE Expression in Thymoma Tissue Associated with Multiple Endocrine Autoimmunity: A Novel Case of APS1. (external link)
• Anette Susanne Bøe Wolff; Kai Kisand; Anthony Meager et al. (2011). Cytokine Antibodies in Autoimmune Polyendocrine Syndrome Type I Correlates to Chronic candidiasis. (external link)
• Eirik Bratland; Eystein Sverre Husebye (2008). 21-hydroxylase as a T cell autoantigen in autoimmune Addison's disease. (external link)
• Bergithe Eikeland Oftedal; Anette Susanne Bøe Wolff; Olle Kämpe et al. (2010). Nucleoporin 62, a Novel Autoantigen in Patients with Autoimmune Polyendocrine Syndrome Type I (APS I). (external link)
• A Hellesen; Eirik Bratland; Eystein Sverre Husebye (2012). Poly (I:C)-induced CXCL10 production in adrenocortical cells - implications for autoimmune Addison's disease?. (external link)
• Richard Alexander Hellesen; Eirik Bratland; Eystein Sverre Husebye (2011). Endogenous Production of CXC Chemokine Ligand 10 (CXCL10) by Adrenocortical Cells and its Implications for Autoimmune Addison's Disease. (external link)
• Eirik Bratland; Anette Susanne Bøe Wolff; Jan Haavik et al. (2007). Epitope mapping of human aromatic L-amino acid decarboxylase. (external link)
• Martina M. Erichsen; Eystein Sverre Husebye; Alv A Dahl et al. (2010). Sexuality, Fertility and Androgens in Women with Addison's Disease. (external link)
• Marissa Penna-Martinez; Julia M. Schwartz; Faroquhi Shoghi et al. (2013). Human leukocyte antigen (DQ2/DQ8) and 21-hydroxylase antibodies determine the thyroid peroxidase antibody status of patients in autoimmune Addison's disease. (external link)
• Ileana Mihaela Cuida Marthinussen; Martina Moter Erichsen; Malin V Jonsson et al. (2011). Oral manifestations of autoimmune polyendocrine syndrome type I. (external link)
• Anette Susanne Bøe Wolff; Kai Kisand; Anthony Meager et al. (2011). Cytokine Antibodies in Autoimmune Polyendocrine Syndrome Type I Correlates to Chronic candidiasis. (external link)
• Eirik Bratland; Eystein Sverre Husebye (2008). 21-hydroxylase as a T cell autoantigen in autoimmune Addison's disease. (external link)
• Bergithe Eikeland Oftedal; Anette Susanne Bøe Wolff; Olle Kämpe et al. (2010). Nucleoporin 62, a Novel Autoantigen in Patients with Autoimmune Polyendocrine Syndrome Type I (APS I). (external link)
• A Hellesen; Eirik Bratland; Eystein Sverre Husebye (2012). Poly (I:C)-induced CXCL10 production in adrenocortical cells - implications for autoimmune Addison's disease?. (external link)
• Marissa Penna-Martinez; Julia M. Schwartz; Faroquhi Shoghi et al. (2013). Human leukocyte antigen (DQ2/DQ8) and 21-hydroxylase antibodies determine the thyroid peroxidase antibody status of patients in autoimmune Addison's disease. (external link)
• Ileana Mihaela Cuida Marthinussen; Martina Moter Erichsen; Malin V Jonsson et al. (2011). Oral manifestations of autoimmune polyendocrine syndrome type I. (external link)

Professional article

• Ingrid Nermoen; Eystein Sverre Husebye; Anne Grethe Myhre et al. (2017). Klassisk medfødt binyrebarkhyperplasi. (external link)
• Eystein Sverre Husebye; Martina Ericksen; A-G Myhre et al. (2012). Nytt steroidkort ved binyrebarksvikt. (external link)
• Eystein Sverre Husebye; Martina Ericksen; A-G Myhre et al. (2012). Nytt steroidkort ved binyrebarksvikt. (external link)

Academic literature review

• Hanna Nowotny; S. Faisal Ahmed; Sophie Bensing et al. (2021). Therapy options for adrenal insufficiency and recommendations for the management of adrenal crisis. (external link)
• Eystein Sverre Husebye; Mark S. Anderson (2010). Autoimmune polyendocrine syndromes: clues to type 1 diabetes pathogenesis. (external link)
• Anna-Karin Åkerman; Åse Bjorvatn Sævik; Per Medbøe Thorsby et al. (2023). Plasma-Metanephrines in Patients with Autoimmune Addison’s Disease with and without Residual Adrenocortical Function. (external link)
• Sandra Dis Steintorsdottir; Marianne Øksnes; Anders Palmstrøm Jørgensen et al. (2025). Extended-release Hydrocortisone Formulations - Is There a Clinically Meaningful Benefit?. (external link)
• Eystein Sverre Husebye; Simon H. Pearce; Nils P. Krone et al. (2021). Adrenal insufficiency. (external link)
• Anette Susanne Bøe Wolff; Sarah Braun; Eystein Sverre Husebye et al. (2021). B cells and autoantibodies in aire deficiency. (external link)
• Eystein Sverre Husebye; Mark S. Anderson; Olle Kämpe (2018). Autoimmune polyendocrine syndromes. (external link)
• Sophie Bensing; Anna-Lena Hulting; Eystein Sverre Husebye et al. (2016). Management of endocrine disease - Epidemiology, quality of life and complications of primary adrenal insufficiency: A review. (external link)
• Sergueï O. Fetissov; Sophie Bensing; Jan Mulder et al. (2009). Autoantibodies in autoimmune polyglandular syndrome type I patients react with major brain neurotransmitter systems. (external link)
• Qian Zhang; Paul Bastard; Adem Karbuz et al. (2022). Human genetic and immunological determinants of critical COVID-19 pneumonia. (external link)
• Kristian Løvås; Eystein Sverre Husebye (2008). Replacement therapy for Addison's disease: recent developments. (external link)
• Jakub Abramson; Eystein Sverre Husebye (2016). Autoimmune regulator and self-tolerance - molecular and clinical aspects. (external link)
• Qian Zhang; Paul Bastard; Adem Karbuz et al. (2022). Human genetic and immunological determinants of critical COVID-19 pneumonia. (external link)
• Kristian Løvås; Eystein Sverre Husebye (2008). Replacement therapy for Addison's disease: recent developments. (external link)
• Jakub Abramson; Eystein Sverre Husebye (2016). Autoimmune regulator and self-tolerance - molecular and clinical aspects. (external link)

Master’s thesis

• Eirik Bratland; Eystein S.Junior Husebye; Anne Marie Szilvay (2005). Cellular immunity in autoimmune Addison's disease. (external link)
• Yeweyenhareg Feleke; Eystein S.Junior Husebye (2005). Studies of Addison's disease in Ethiopia. (external link)

Doctoral thesis (PhD)

• Grethe Åstrøm Ueland; Eystein Sverre Husebye; Paal Methlie et al. (2019). Improved diagnostic workup of hyper- and hypocortisolism. (external link)
• Anette Susanne Bøe; Eystein S.Junior Husebye (2005). Immunological perspectives of autoimmune polyendocrine syndromes and cancer. (external link)
• Eystein S.Junior Husebye (1990). Stimulus-secretion coupling in chromaffin cells of the bovine adrenal medulla : with special reference to the role of phospholipid metabolism. (external link)
• Ingeborg Brønstad; Eystein Sverre Husebye (2015). Genetics of autoimmune Addison´s disease and congenital adrenal hyperplasia. (external link)

Research report

• Eystein S.Junior Husebye (2000). Feokromocytom i Neuroindokrine tumorer, en veiledning til diagnostikk og behandling. (external link)
• Eystein Husebye (2000). Feokromocytom i Neuroindokrine tumorer, en veiledning til diagnostikk og behandling. (external link)

Academic book chapter

• Eystein Husebye (2003). Cushings syndrom. (external link)
• Anette Susanne Bøe Wolff; Bergithe Eikeland Oftedal; Eystein Sverre Husebye (2019). The Natural History of APS1. (external link)

Textbook

• Eystein Sverre Husebye; Kristian Løvås (2017). Endokrinologi, en medisinsk lærebok. (external link)

Letter to the editor

• Cecilie Smith Ødegaard; May Brit Samersaw-Lund; Radek Frič et al. (2024). Etisk ryggrad i møte med politisk konflikt. (external link)
• Marianne Grytaas; Lars Ertesvåg Breivik; Jørgensen Anders Palmstrøm et al. (2020). Medisinsk koding til besvær. (external link)
• Daniel Eriksson; Rosa Bacchetta; Hörður Ingi Gunnarsson et al. (2019). The autoimmune targets in IPEX are dominated by gut epithelial proteins. (external link)
• Eystein Sverre Husebye (2008). Endokrinologisk akuttmedisin. (external link)
• Marcus Quinkler; Per Dahlqvist; Eystein Sverre Husebye et al. (2015). A European Emergency Card for adrenal insufficiency can save lives. (external link)
• Kristian Løvås; Eystein S.Junior Husebye (2005). Addison's disease. (external link)
• Petter Brodin; Giorgio Casari; Liam Townsend et al. (2022). Studying severe long COVID to understand post-infectious disorders beyond COVID-19. (external link)
• Kristian Løvås; Eystein S.Junior Husebye (2004). Replacement therapy in Addison&apos;s disease. (external link)
• Eystein Sverre Husebye (2012). E. S. Husebye svarer. (external link)
• Eystein Sverre Husebye (2012). E. S. Husebye svarer. (external link)

Lecture

• Eystein S.Junior Husebye (1997). Adrenal insufficiency, diagnostic and molecular biology. (external link)
• Eystein S.Junior Husebye (1997). Autoantibodies against L-amino acid decarboxylase delineate a subgroup of patients with Addison's disease. (external link)

Editorial/Leader article

• Eystein Husebye (2002). Hypotyreose. (external link)
• Eystein Sverre Husebye (2009). Functional autoantibodies cause hypoparathyroidism. (external link)
• Ian Louis Ross; Eystein Sverre Husebye; Michelle Henry (2023). Editorial: Glucocorticoids and cognition: recent advances in understanding their interaction, with a particular focus on clinical applicability for the treating endocrinologist. (external link)
• Eystein Sverre Husebye (2009). Editorial: Functional Autoantibodies Cause Hypoparathyroidism. (external link)
• Eystein Husebye (2002). Hypotyreose. (external link)
• Eystein Sverre Husebye (2009). Editorial: Functional Autoantibodies Cause Hypoparathyroidism. (external link)

Non-fiction book chapter

• Eystein Sverre Husebye (2017). Binyresykdommer. (external link)
• Eystein Sverre Husebye (2017). Binyresykdommer. (external link)

See a complete overview of publications in NVA.

Co-ordinator of the EU FP7 project Euradrenal